224 related articles for article (PubMed ID: 7026510)
1. [Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase].
Bauer HW; Schüller J; Schmiedt E; Dati F
Helv Chir Acta; 1981 Aug; 48(3-4):459-63. PubMed ID: 7026510
[TBL] [Abstract][Full Text] [Related]
2. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
Bauer HW; Schmiedt E
Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
[TBL] [Abstract][Full Text] [Related]
3. [The significance of serum gamma-seminoprotein in prostatic cancer].
Ishikawa S; Tozuka K; Ishiyama S; Goto K; Ohba S; Tokue A; Yonese Y; Kamachi S; Sakurabayashi I; Kawai T
Hinyokika Kiyo; 1985 Jun; 31(6):961-7. PubMed ID: 2414979
[TBL] [Abstract][Full Text] [Related]
4. A new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer (SPIF).
Wajsman Z; Lee CL; Chu TM; Murphy GP
Surg Forum; 1979; 30():568-9. PubMed ID: 395710
[No Abstract] [Full Text] [Related]
5. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
Bauer HW
Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
[No Abstract] [Full Text] [Related]
6. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
Rassweiler J; Lutz K; Müller HA; Eisenberger F
Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
[TBL] [Abstract][Full Text] [Related]
7. [Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients].
Yamanaka H; Yuasa H; Natori E; Imai K; Mashimo T
Rinsho Byori; 1987 Oct; 35(10):1154-8. PubMed ID: 3325662
[No Abstract] [Full Text] [Related]
8. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Canal P; Soula G
Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of a monoclonal antibody-based enzyme immunoassay (IQ(Bio) PAP-AELIA kit) for prostatic acid phosphatase].
Koshida K; Naito K; Hisazumi H
Hinyokika Kiyo; 1987 Oct; 33(10):1703-7. PubMed ID: 3328502
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
Vihko P; Lukkarinen O; Kontturi M; Vihko R
Cancer Res; 1981 Mar; 41(3):1180-3. PubMed ID: 7459859
[TBL] [Abstract][Full Text] [Related]
11. Prostatic acid phosphatase: current concepts.
Romas NA
Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
Okabe H; Noma A; Nakauchi K; Mori M
Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
[No Abstract] [Full Text] [Related]
13. [Prostatic acid phosphatase measured by immunoenzyme assay].
Fuse H; Zama S; Shimazaki J
Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers in prostate cancer].
Kuriyama M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
[TBL] [Abstract][Full Text] [Related]
15. [Determination of acid phosphatase in prostatic carcinoma].
Bauer HW; Walther V; Schmiedt F
Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
[TBL] [Abstract][Full Text] [Related]
16. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
17. [Prostatic acid phosphatase by enzymeimmunoassay].
Masukagami T; Ando K; Shimazaki J
Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
[TBL] [Abstract][Full Text] [Related]
18. [Determination of tumor markers in the diagnosis of prostatic cancer].
Casas Terrón E; Mari Ruiz M; Molina Andreu E
Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
[TBL] [Abstract][Full Text] [Related]
19. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
20. [Current assessment of radioimmunological determination (RIA) of prostate acid phosphatase in the diagnosis of prostatic cancer].
Huber PR; Hagmaier V; Scholer A; Lyrer P; Christen P; Wolf T; Kanszo G; Hassel JP; Rutishauser G
Helv Chir Acta; 1981 Aug; 48(3-4):445-52. PubMed ID: 7287483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
